DEA Moves to Watch Everyday Chemicals Used for Fentanyl
Published Date: 7/9/2026
Proposed Rule
Summary
The DEA wants to add phenethyl halides to a special list of chemicals that are closely watched because they can be used to make illegal fentanyl. This means anyone handling these chemicals will have to follow new rules starting soon, no matter how much they have. If you work with these chemicals, get ready to comply and share your thoughts by August 10, 2026!
Analyzed Economic Effects
6 provisions identified: 1 benefits, 4 costs, 1 mixed.
Security, inspections, and legal liability
Handlers would need to implement effective controls against theft and diversion per 21 CFR 1309.71-1309.73, be subject to administrative inspections of controlled premises, and face administrative, civil, or criminal liability for unauthorized activities involving phenethyl halides. Import/export activity must comply with 21 CFR part 1313.
All phenethyl transactions regulated
If finalized, every domestic and international transaction of phenethyl halides will be regulated under the Controlled Substances Act no matter the size or concentration. Chemical mixtures that contain any amount of phenethyl halides will also be treated as regulated unless DEA grants an exemption by application.
Handlers must register with DEA
Manufacturers, distributors, importers, and exporters of phenethyl halides must obtain DEA registrations to handle these chemicals. DEA identifies the annual registration fee amounts: $3,699 for manufacturers and $1,850 for distributors, importers, and exporters, and requires separate registrations by activity and by each principal business location.
30‑day temporary registration exemption
DEA proposes a temporary exemption from the registration requirement for persons who submit a properly completed registration application or an application to exempt a chemical mixture on or before 30 days after publication of a final rule. That temporary exemption applies only to registration; all other controls like recordkeeping and reporting become effective on the final rule's effective date.
Recordkeeping, reporting, and annual data rules
Registered handlers must keep records for two years for regulated transactions and submit annual manufacturing, inventory, and use data if they are a regulated bulk manufacturer. They must also report extraordinary quantities, unusual payment or delivery methods, losses, or any transaction they suspect may indicate diversion.
Mixture exemption application path
Manufacturers of mixtures that contain phenethyl halides can apply to DEA for an exemption under 21 CFR 1310.13; DEA may exempt a mixture if it determines the listed chemical cannot be readily recovered and the mixture cannot be easily used to make illegal drugs. Automatic exemptions under 21 CFR 1310.12(d) may also apply if criteria are met.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20552, Wellwise Pharmacy Inc.; Decision and Order
Wellwise Pharmacy in Texas had its DEA registration suspended and is facing revocation because it kept filling risky prescriptions for controlled drugs without checking warning signs. This affects the pharmacy’s ability to legally handle these medicines, protecting public health and safety. The decision took effect immediately in late 2025, stopping Wellwise from operating under its DEA license and signaling serious legal and financial trouble ahead.
2026-20535, Arenbii Pharmacy LLC; Decision and Order
Arenbii Pharmacy in Texas lost its DEA license because it kept filling risky drug prescriptions without fixing obvious problems. This means they can’t legally handle certain controlled medicines anymore, protecting public safety. The decision is final, and Arenbii didn’t ask for a hearing, so the revocation starts now with no chance to appeal.
Previous / Next Documents
Previous: C1-2026-12542, Naturalization Application Fee Adjustments
Starting soon, people applying to become U.S. citizens might see some changes in the fees they pay. If you can’t afford the fee, you can ask for a waiver using a special form that helps speed up the decision. This update affects individuals and households applying for naturalization and aims to make fee waivers clearer and faster.
Next: 2026-13834, Request for Information Regarding Promoting Access to Mortgage Credit
The Consumer Financial Protection Bureau wants your ideas on how to make it easier for people to get home loans by cutting confusing rules and paperwork. This affects anyone looking to borrow money for a mortgage, especially first-time buyers and seniors with reverse mortgages. Share your thoughts by August 10, 2026, to help shape simpler, fairer mortgage rules that could save time and money.